⚠️ Excess acetylcholine can cause SLUDE syndrome (Salivation, Lacrimation, Urination, Defecation, Emesis).
This reflects pathological overstimulation of the parasympathetic nervous system, such as in nerve gas exposure or overdose.
💊 About
- Always check the BNF or equivalent for prescribing advice.
- Acetylcholinesterase inhibitors are mainly used in dementia and neurological disorders.
- Similar mechanisms are seen in toxic exposures (e.g. organophosphates, nerve gases).
⚙️ Mode of Action
- Inhibit acetylcholinesterase, the enzyme responsible for breaking down acetylcholine (ACh).
- Increase both the level and duration of action of acetylcholine at synapses.
- Enhance cholinergic transmission, especially in the CNS and parasympathetic nervous system.
💊 Examples
- Donepezil (Aricept): tablets and oral dispersible tablets. Dosage: 5–10 mg daily.
- Galantamine (Reminyl XL): tablets, capsules, and liquid. Dosage: 8–24 mg once daily.
- Rivastigmine (Exelon): tablets and liquid (1.5–6 mg twice daily) or transdermal patches (4.6–9.5 mg once daily).
⚡ Clinical Side Effects
- Cholinergic overstimulation (muscarinic effects):
- Salivation, lacrimation, sweating.
- Urination, defecation, nausea, vomiting.
- Miosis (pupil constriction).
- Bradycardia, hypotension.
- Bronchospasm, increased bronchial secretions.
- These effects are mediated via muscarinic receptors.
📋 Indications / Dose
- Alzheimer’s disease (mild to moderate stages).
- Other dementias (e.g. Lewy body dementia, Parkinson’s disease dementia).
🔄 Interactions
- See BNF for full list.
- Potential interactions with anticholinergics (antagonistic effect).
- Risk of bradycardia with beta-blockers or digoxin.
⚠️ Cautions
- History of asthma, COPD, or bronchospasm.
- Peptic ulcer disease (↑ gastric acid secretion).
- Seizure disorders.
- Bradycardia or conduction abnormalities.
⛔ Contraindications
- Severe hepatic impairment (drug-specific).
- Uncontrolled cardiac conduction disorders (e.g. sick sinus syndrome, AV block).
- Known hypersensitivity to drug or excipients.
🛑 When to Stop Acetylcholinesterase Inhibitors
Examples: Donepezil, Rivastigmine, Galantamine.
Always check NICE NG97 or the BNF for up-to-date guidance.
- Advanced dementia: Stop if patient has progressed to severe/end-stage dementia with no meaningful cognitive, functional, or behavioural benefit.
- Intolerable side effects: Severe nausea, diarrhoea, weight loss, bradycardia, syncope, recurrent falls, worsening asthma/COPD, or peptic ulcer complications.
- No clinical benefit: Continued deterioration despite 3–6 months of treatment at optimal dose.
- Practical issues: Poor adherence, patient refuses medication, or carers unable to administer safely.
- New contraindication: Development of severe heart block, sick sinus syndrome, or severe renal/hepatic impairment.
- Shared decision-making: If patient (with capacity) or family request discontinuation after weighing risks and benefits.
🧠 Clinical Notes
- Review treatment every 6–12 months (NICE guidance).
- Discontinue gradually (taper where possible) to avoid rebound confusion or behavioural worsening.
- Some clinicians consider a short "drug holiday" if uncertain benefit, and restart if marked decline is observed.
📚 References